CIK: 0001232621
Total reported value
$2.0B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HRTX | Heron Therapeutics INC | Stock-Other | 28.07% | -0.15% | +11.58% | |
| 2 | PDLI 2.875 02-15-15 * | Pdl Bio Pharma INC | Stock-Other | 22.17% | — | — | |
| 3 | ✓ | Salix Pharmaceuticals INC | Stock-Other | 17.14% | — | — | |
| 4 | OPK 3 02-01-33 144A | Opko Health INC | Stock-Other | 8.68% | — | — | |
| 5 | ✓ | Horizon Pharma INC | Stock-Other | 7.33% | — | — | |
| 6 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 5.25% | — | — | |
| 7 | LJPC | La Jolla Pharmaceutical Co | Stock-Other | 3.75% | — | +7760.83% | |
| 8 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | Stock-Other | 3.47% | — | — | |
| 9 | MRTXEUR | Mirati Therapeutics INC | Stock-Other | 2.67% | — | -33.82% | |
| 10 | ✓ | Endocyte INC | Stock-Other | 1.42% | — | — | |
| 11 | ✓ | Dendreon CORP | Stock-Other | 0.06% | — | — | |
| 12 | ✓ | Ambit Biosciences CORP | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LJPC | La Jolla Pharmaceutical Co | +3.7% | +7760.83% | Add |
| 2 | PDLI 2.875 02-15-15 * | Pdl Bio Pharma INC | +2.7% | — | Unchanged |
| 3 | ✓ | Salix Pharmaceuticals INC | +2.1% | — | Unchanged |
| 4 | ✓ | Horizon Pharma INC | — | — | Unchanged |
| 5 | ✓ | Ambit Biosciences CORP | — | — | Unchanged |
| 6 | ✓ | Dendreon CORP | 0% | — | Unchanged |
| 7 | OPK 3 02-01-33 144A | Opko Health INC | -0.6% | — | Unchanged |
| 8 | BMRN | Biomarin Pharmaceutical INC | -0.8% | — | Unchanged |
| 9 | MRTXEUR | Mirati Therapeutics INC | -1.4% | -33.82% | Trim |
| 10 | HRTX | Heron Therapeutics INC | -1.7% | +11.58% | Add |
| 11 | ✓ | Endocyte INC | -4% | — | Unchanged |
| 12 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | — | NEW | New buy |
| 13 | MNKD | MannKind Corporation | — | EXIT | Sold out |
| 14 | ✓ | Rxi Pharmaceuticals CORP | — | EXIT | Sold out |